KROS · Keros Therapeutics, Inc.
$9.93
-0.14 (-1.39%)
At close · Jul 29
Market Cap
$199.30M
Shares
19.79M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 289,302 | 302,087 | 591,389 | 40.0% |
| 2026-04-27 | 230,396 | 172,437 | 402,833 | 35.7% |
| 2026-04-20 | 185,117 | 163,475 | 348,592 | 31.8% |
| 2026-04-13 | 296,842 | 192,718 | 489,560 | 32.3% |
| 2026-04-06 | 415,125 | 208,214 | 623,339 | 37.8% |
| 2026-03-30 | 360,933 | 225,544 | 586,477 | 38.2% |
| 2026-03-23 | 464,686 | 164,304 | 628,990 | 31.3% |
| 2026-03-16 | 594,827 | 824,933 | 1,419,760 | 35.4% |
| 2026-03-09 | 910,933 | 305,288 | 1,216,221 | 38.1% |
| 2026-03-02 | 534,162 | 215,657 | 749,819 | 29.6% |
| 2026-02-23 | 365,829 | 232,169 | 597,998 | 34.0% |
| 2026-02-16 | 312,785 | 102,498 | 415,283 | 31.7% |
| 2026-02-09 | 268,009 | 172,869 | 440,878 | 34.3% |
| 2026-02-02 | 254,713 | 136,890 | 391,603 | 27.1% |
| 2026-01-26 | 239,375 | 176,267 | 415,642 | 36.4% |
| 2026-01-19 | 329,536 | 117,383 | 446,919 | 39.9% |
| 2026-01-12 | 412,117 | 314,902 | 727,019 | 39.6% |
| 2026-01-05 | 450,317 | 397,528 | 847,845 | 34.3% |
| 2025-12-29 | 240,393 | 208,465 | 448,858 | 35.3% |
| 2025-12-22 | 376,878 | 191,675 | 568,553 | 33.4% |
| 2025-12-15 | 570,482 | 725,308 | 1,295,790 | 31.2% |
| 2025-12-08 | 714,959 | 389,987 | 1,104,946 | 34.7% |
| 2025-12-01 | 1,131,345 | 1,435,482 | 2,566,827 | 42.1% |
| 2025-11-24 | 953,531 | 1,129,116 | 2,082,647 | 37.1% |
| 2025-11-17 | 1,125,838 | 1,939,025 | 3,064,863 | 46.0% |
| 2025-11-10 | 1,330,802 | 740,082 | 2,070,884 | 31.0% |
| 2025-11-03 | 1,223,317 | 457,720 | 1,681,037 | 26.3% |
| 2025-10-27 | 890,646 | 689,894 | 1,580,540 | 32.5% |
| 2025-10-20 | 1,126,645 | 775,425 | 1,902,070 | 34.3% |
| 2025-10-13 | 2,006,425 | 2,580,538 | 4,586,963 | 47.5% |
| 2025-10-06 | 483,663 | 236,426 | 720,089 | 32.5% |
| 2025-09-29 | 307,040 | 1,220,986 | 1,528,026 | 50.7% |
| 2025-09-22 | 267,053 | 157,135 | 424,188 | 32.7% |
| 2025-09-15 | 244,114 | 239,094 | 483,208 | 28.1% |
| 2025-09-08 | 246,835 | 153,650 | 400,485 | 31.9% |
| 2025-09-01 | 238,674 | 561,107 | 799,781 | 46.1% |
| 2025-08-25 | 412,308 | 629,329 | 1,041,637 | 47.8% |
| 2025-08-18 | 791,401 | 567,182 | 1,358,583 | 41.0% |
| 2025-08-11 | 509,371 | 333,969 | 843,340 | 41.2% |
| 2025-08-04 | 453,894 | 440,491 | 894,385 | 36.0% |
Showing 1–40 of 40 weeks
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
19 filings
19 filers
Visit website
Investor relations